FTC sues big pharmacy benefit administrators more than insulin rates The agency introduced action in opposition to Caremark, Categorical Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating methods “artificially inflated” the checklist price of daily life-saving insulin prescription drugs. You should not miss tomorrow's healthcare industry news Let https://erickzqixn.liberty-blog.com/30752343/everything-about-healthcare-news